Introduction
Following the decision by Thailand’s new Prime Minister, Strettha Thavisin, to amend the country’s cannabis policy, it appears that authorities are preparing to implement a stricter regulatory framework, limiting its use to medical purposes. This measure aims to curb the uncontrolled sale of recreational cannabis that has grown since its decriminalization last year.
The reasons behind this policy change In an interview with Bloomberg, Mr. Thavisin stated that it was necessary to rewrite the law
in order to stem the proliferation of outlets offering cannabis for non-medical purposes. According to Thanet Supornsahasrungsi, executive director of the Sunshine Hotels and Resorts Group in Pattaya, “it is now easy to find a cannabis shop every 200 to 300 meters on the streets of Pattaya, and 90% of them are not for medical use.” The previous governing coalition had decriminalized cannabis to allow local farmers to capitalize on the plant’s economic potential and promote research into its medical applications. However, this also paved the way for a thriving black market for recreational products.
The Impact on the Cannabis Industry in Thailand Despite the new Prime Minister’s firm stance, Thailand’s nascent cannabis industry remains largely unaffected for now.
However, it is clear that the authorities are seeking to implement a stricter regulatory framework tailored to the current situation. Following this decision, many companies are expected to seek licenses to meet the legal requirements for selling and cultivating cannabis for medical purposes.
Next Steps for Regulating the Medical Cannabis Market
- The Prime Minister has announced his intention to restructure cannabis policy within six months. Among the measures under consideration are stricter controls on cannabis distribution and the introduction of special permits for producers and distributors to ensure product quality and safety. Production and Distribution Licenses:
- It is likely that companies will need to obtain licenses to cultivate, manufacture, and distribute cannabis products for medical use. Quality Control:
- Higher quality standards will likely be implemented to ensure the safety and efficacy of cannabis-based medicines for patients. Accountability:
Companies will likely be held accountable for the products they place on the market, with penalties for failing to meet regulatory and legal requirements.
